Breathe Well Live Well
|
Teva Pharma (TEVA) Receives FDA Approval for ProAir RespiClick for Pediatric Asthma Patients Ages 4 to 11
StreetInsider.com “The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of asthma … |
View full post on asthma – Google News
The Inquisitr |
FDA Gives Teva Go-Ahead on Asthma Drug
http://hamodia.com YERUSHALAYIM – The U.S. Food and Drug Administration (FDA) has announced approval of a new asthma treatment developed by the Israeli-based firm Teva, Globes reported on Sunday. CINQAIR injection for severe asthma sufferers is taken once every … FDA approves Cinqair to treat severe asthma Asthma Attacks Face Newly Approved Super Treatment 'Cinqair' Reslizumab (Cinqair) Approved to Treat Severe Asthma |
View full post on asthma – Google News
Fox News |
FDA advisers recommend approval of Teva asthma drug in adults
Fox News An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's. The panel voted unanimously that the drug should not be approved for children aged 12 to 17. US FDA advisers recommend approval of Teva asthma drug for adults FDA Advisory Committee Recommends Approval of Teva's Asthma Biologic Reslizumab |
View full post on asthma – Google News
Reuters |
US FDA advisers recommend approval of Teva asthma drug for adults
Reuters An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's <TEVA.TA) experimental drug reslizumab for severe asthma in patients aged 18 and older. Ad Comm tomorrow for Teva's asthma candidate reslizumab |
View full post on asthma – Google News
|
Teva Announces European Medicines Agency (EMA) Confirms Successful Validation …
MarketWatch “Uncontrolled asthma remains a serious challenge for patients and healthcare professionals despite the availability of standard of care treatment,” said Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical … |
View full post on asthma – Google News
Lung Disease News |
Teva Announces FDA Acceptance of Reslizumab For Asthma
Lung Disease News Reslizumab is being developed as treatment of inadequately controlled asthma in adults and young people who have increased blood eosinophils, despite being under treatment with an inhaled corticosteroid (ICS) drug regimen. “Despite currently available … FDA to review Teva asthma biologic FDA will review Teva's asthma biologic reslizumab Stock Update (NYSE:TEVA): Teva Pharmaceuticals Industries Ltd (ADR … |
View full post on asthma – Google News
Bidness ETC |
Teva Pharmaceutical Industries Ltd Gets FDA Green Signal For Its Acute Asthma …
Bidness ETC Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA), the world's largest seller of generic drugs based in Israel, has yet another victory to add to its success story. Its acute asthma inhaler has finally pocketed the approval from the US Food and … First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma Approved FDA approves ProAir RespiClick for treatment of acute asthma symptoms FDA clears Teva asthma med (TEVA) |
View full post on asthma – Google News
Nasdaq |
FDA clears Teva asthma med (TEVA)
Seeking Alpha (registration) The FDA approves Teva Pharmaceutical Industries' (NYSE:TEVA) ProAir RespiClick (albuterol sulfate) inhalation powder for the treatment or prevention of bronchospasm in patients at least 12 years old with reversible obstructive airway disease and for … Teva Announces FDA Approval of ProAir® RespiClick Teva Announces FDA Approval of ProAir(R) RespiClick |
View full post on asthma – Google News
|
Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks
Motley Fool Asthma is one of the planet's more common diseases. It affects roughly 300 million people and despite the availability of treatment designed to help reduce asthma attacks, millions of people's asthma is poorly controlled. As a result, a host of … |
View full post on asthma – Google News
Globes |
Teva finds positive results in advanced trials for asthma drug
Yahoo News TEL AVIV (Reuters) – Teva Pharmaceutical Industries said a drug under development had positive results in reducing the frequency of clinical asthma exacerbations in two advanced trials in patients with moderate to severe asthma. Reslizumab, an … Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies Teva reports positive Phase III asthma drug results |
View full post on asthma – Google News